Outstanding Clarifications Needed:

[ ] What ILPA committee is Nick involved with?
[ ] Which stakeholder debates are currently most sensitive?
[ ] Are there key talking points Nick would like emphasized or avoided?
[ ] [ ]Is there any client or regulatory pressure driving this article timing?
[ ] What are the key points of debate among stakeholders?
[ ] Any sensitive areas to carefully navigate?
